Treatment for leishmaniasis
Not Applicable
- Conditions
- Cutaneous leishmaniasis
- Registration Number
- SLCTR/2014/028
- Lead Sponsor
- Base Hospital Hambanthota
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
1.>12 years of age
2.Positive slit skin smear and /or skin biopsy for leishmania parasites
Exclusion Criteria
1.Pregnancy
2.Breast feeding
3.Known renal impairment
4.Known liver impairment
5.Congestive cardiac failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Rate of clinical cure <br>2. Side effects to drugs – anticipated local side effects are pain, ulceration, scarring, post inflammatpry hyperpigmentation or depigmentation. (Systemic side effects are not anticipated as the drug is given intralesional)<br><br><br> [1. At 12 weeks <br>2. Weekly until end of the intralesional therapy, then every 3 months for a total of 12 months]<br>
- Secondary Outcome Measures
Name Time Method 1.Recurrence rate<br>2.Evidence of viceralization [Every 3 months from clinical cure for a total of 12 months]<br>